Okładka

Efficacy of pazopanib in FGFR1-amplified uterine carcinosarcoma: A case report

Zapisane w:

Opis bibliograficzny
Główni autorzy:	Saki Sawayama (Autor), Ryusuke Murakami (Autor), Megumi Aki (Autor), Yusuke Kawaguchi (Autor), Yumi Takao (Autor), Hirofumi Nonogaki (Autor), Tomoyuki Goto (Autor), Chikako Yamauchi (Autor)
Format:	Książka
Wydane:	Elsevier, 2022-06-01T00:00:00Z.
Hasła przedmiotowe:	article
Dostęp online:	Connect to this object online.
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy

Phototoxic Reaction Induced by Pazopanib
od: Siriorn Udompanich, i wsp.
Wydane: (2018)

Secondary uterine carcinosarcoma after concurrent chemoradiotherapy for cervical cancer: Case reports
od: Akihiko Wakayama, i wsp.
Wydane: (2017)

Pazopanib for the treatment of soft-tissue sarcoma
od: Heudel P, i wsp.
Wydane: (2012)

Pazopanib-mediated long-term disease stabilization after resection of a uterine leiomyosarcoma metastasis to the brain: A case report
od: Kayo Inoue, i wsp.
Wydane: (2016)

Carcinosarcoma of lung
od: S Neupane, i wsp.
Wydane: (2013)

Carcinosarcoma of the gallbladder
od: Agarwal Tanu, i wsp.
Wydane: (2009)

Uterine Carcinosarcoma in a Patient with Didelphys Uterus
od: C. Iavazzo, i wsp.
Wydane: (2013)

Fatal pulmonary thromboembolism associated with uterine carcinosarcoma
od: Giorgia Lodetti, i wsp.
Wydane: (2023)

Rare case of rapid hair depigmentation with Pazopanib
od: Ephraïm Lonté Kintossou, i wsp.
Wydane: (2023)

Pazopanib in the management of advanced soft tissue sarcomas
od: Cranmer LD, i wsp.
Wydane: (2016)

Clostridium and Bacteroides bacteremia as initial presentation of uterine carcinosarcoma
od: Chinonye S. Imo, i wsp.
Wydane: (2022)

Uterine Carcinosarcoma: A Case Report and Literature Review
od: Ali Kord, i wsp.
Wydane: (2020)

Cutaneous metastasis of uterine carcinosarcoma mimicking drug eruption
od: Katherine L. Wang, BS, i wsp.
Wydane: (2024)

Surgical Resection and Pazopanib Treatment for Recurrent Cardiac Angiosarcoma
od: Yuki Nakamura, i wsp.
Wydane: (2019)

Carcinosarcoma de endometrio
od: Enrique Leaño P.
Wydane: (1973)

Advanced Composite of Large Cell Neuroendocrine Carcinoma and Squamous Cell Carcinoma: A Case Report of Uterine Cervical Cancer in a Virgin Woman
od: Ryusuke Murakami, i wsp.
Wydane: (2013)

Species differences in ocular pharmacokinetics and pharmacological activities of regorafenib and pazopanib eye‐drops among rats, rabbits and monkeys
od: Shinya Horita, i wsp.
Wydane: (2019)

Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcoma
od: Jonathan T. Hunt, i wsp.
Wydane: (2021)

Uterine carcinosarcoma associated with a germline nibrin (NBN) mutation
od: Tahireh Markert, i wsp.
Wydane: (2022)

Profile of pazopanib and its potential in the treatment of epithelial ovarian cancer
od: Davidson BA, i wsp.
Wydane: (2014)

Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma
od: Sabrina Rossetti, i wsp.
Wydane: (2017)

Population Pharmacokinetic Analysis of Pazopanib in Patients and Determination of Target AUC
od: Agustos Cetin Ozbey, i wsp.
Wydane: (2021)

Effectiveness of combined low-dose radiotherapy and pazopanib for controlling the local manifestations of taxane-resistant recurrent angiosarcoma of the head
od: Hiroshi Kato, MD, PhD, i wsp.
Wydane: (2020)

Effect of FGFR alteration on prognosis in 1963 urothelial carcinoma patients with immune checkpoint inhibitors: Implying combination of FGFR inhibitor and immunotherapy for FGFR-altered urothelial carcinoma
od: Yuxuan Song, i wsp.
Wydane: (2024)

Clinically aggressive "low-grade" uterine carcinosarcoma: A case report
od: Theresa Clearman, i wsp.
Wydane: (2015)

Non-islet cell tumor hypoglycemia in a patient with uterine carcinosarcoma
od: Miller P. Singleton, i wsp.
Wydane: (2022)

The efficacy and safety of lenvatinib plus pembrolizumab therapy in patients with uterine carcinosarcoma
od: Risako Ozawa, i wsp.
Wydane: (2024)

Uterine cervical carcinosarcoma; very rare and aggressive behavior; literature review
od: Özer Birge, i wsp.
Wydane: (2021)

Patterns of adjuvant treatment and survival outcomes in stage I uterine carcinosarcoma
od: Lori Cory, i wsp.
Wydane: (2022)

Eritema escrotal como manifestación inicial de toxicodermia por pazopanib
od: M. Pons Benavent, i wsp.
Wydane: (2021)

Histology-specific FGFR2 alterations and FGFR2-TACC2 fusion in mixed adenoid cystic and neuroendocrine small cell carcinoma of the uterine cervix
od: Corey M. Gill, i wsp.
Wydane: (2020)

Lenvatinib Suppresses Angiogenesis through the Inhibition of both the VEGFR and FGFR Signaling Pathways
od: Kenji Ichikawa, i wsp.
Wydane: (2016)

Management of ovarian carcinosarcomas (review of literature)
od: A. N. Gritsai, i wsp.
Wydane: (2014)

Ovarian carcinosarcoma (a literature review)
od: A. M. Beishembaev, i wsp.
Wydane: (2022)

Carcinosarcoma of Breast - A Diagnostic Challenge
od: Sarandeep Singh Puri, i wsp.
Wydane: (2022)

Recurrent Parotid Carcinosarcoma in an Asymptomatic Patient
od: Joshua Mansour MD, i wsp.
Wydane: (2016)

Role of FGFR3 in Urothelial Carcinoma
od: Malik Akanksha, i wsp.
Wydane: (2019)

An uncommon case of POLE mutated uterine carcinosarcoma − complemented by a review of literature
od: C. Ebner, i wsp.
Wydane: (2024)

Uterine carcinosarcoma associated with pelvic radiotherapy for sacral chordoma: A case report
od: Korhan Kahraman, i wsp.
Wydane: (2012)

Increasing incidence of uterine carcinosarcoma: A United States Cancer Statistics study
od: Cheng-I Liao, i wsp.
Wydane: (2022)